Dr. Gaveras co-founded Talkiatry and personally designed its full-stack clinical model. The company aims to deliver high-quality psychiatry at national scale through deliberate, clinician-led leadership that addresses access, quality and sustainability. Under her leadership, Talkiatry has implemented a model of full-time, W-2 employment for both psychiatrists and therapists, enabling consistent standards of care, continuity for patients and continued investment in clinical infrastructure. This structure has also produced remarkable workforce outcomes, with Talkiatry clinicians reporting 80% less burnout than the industry average. Dr. Gaveras has insisted on clinical validation as a prerequisite for scale, leading multiple peer-reviewed studies evaluating telepsychiatry outcomes involving more than 1,800 patients, with results including 87% of patients experiencing symptom reduction in depression and up to 86% achieving clinical remission in anxiety, directly advancing Talkiatry’s partnerships with payers, employers and health systems, and leading to accelerated adoption of value-based behavioral healthcare nationwide. Prior to Talkiatry, Dr. Gaveras held academic appointments and medical leadership roles at multiple medical institutions. She is a sought-after voice on workforce sustainability, value-based psychiatry and equitable access, having addressed these topics at HLTH, ViVE and the American Telemedicine Association. Dr. Gaveras was named to Inc.‘s 2025 “Female Founders 500,” named a Crain‘s “Notable Health Care Leader” in 2023, and honored as a City and State “Trailblazer in Health Care” for 2025.
